All Conditions
Condition Guide

Fatty Liver Disease (NAFLD/MASLD)

Fatty liver is the most common liver condition worldwide, affecting up to 25% of adults. The good news: caught early, it is fully reversible with the right lifestyle changes.1

Written by Suman Konda, Clinical Pharmacist · Based on peer-reviewed sources · Editorial policy · Not medical advice

Last reviewed and updated: · How we check our content

Quick answer

Fatty liver is the most common liver condition worldwide, affecting up to 25% of adults. Caught early it is fully reversible — and the evidence is blunt: sustained weight loss outperforms every pill or supplement. The crucial distinction is between simple fat (benign) and NASH (inflammation and damage).

What fatty liver disease is

Advertisement

Non-alcoholic fatty liver disease (NAFLD) — now renamed metabolic dysfunction-associated steatotic liver disease (MASLD) — is excess fat accumulation in liver cells (hepatocytes) in people who drink little or no alcohol.2 It covers a spectrum: simple steatosis (fat only, benign in the majority), NASH (non-alcoholic steatohepatitis — fat plus inflammation and cell injury), fibrosis and cirrhosis.

The distinction that matters: about 15–20% of those with simple steatosis develop NASH, and of those with NASH, roughly 15–25% progress to cirrhosis over 10–20 years. NASH is now the second most common indication for liver transplant in the USA. The condition is strongly linked to obesity (especially abdominal fat), type 2 diabetes, insulin resistance and high triglycerides — it travels with metabolic syndrome, not alone.

How fatty liver is usually evaluated

Blood tests support the diagnosis but cannot stage it alone — a normal ALT does not exclude NAFLD or even NASH:

TestTypical finding in fatty liver
ALT (SGPT)Mildly to moderately elevated (1–4× normal); normal in up to 30% of NASH
AST (SGOT)Elevated; AST:ALT ratio usually below 1 (unlike alcoholic liver disease)
GGTOften elevated, particularly with metabolic syndrome
Fasting glucose / HbA1cRaised: insulin resistance is often present
TriglyceridesOften elevated
FerritinOften mildly elevated as an inflammation marker — not the same as haemochromatosis
Albumin / INRNormal in early stages; abnormal suggests cirrhosis

The FIB-4 score — calculated as (age × AST) ÷ (platelets × √ALT) — is the recommended first-line non-invasive fibrosis tool: below 1.3 suggests low fibrosis risk, above 2.67 high risk. Ultrasound grades the fat; FibroScan (liver elastography) assesses fibrosis without a biopsy. Liver biopsy remains the gold standard but is reserved for uncertain cases.1

Your next steps after a fatty liver finding

A “fatty liver” on ultrasound is the start of a plan, not a verdict. Work through these with your doctor:

  1. Find out how advanced it is. Ask for a FIB-4 calculation from your existing bloods and whether a FibroScan is warranted — simple steatosis and NASH need very different levels of attention.
  2. Target 7–10% weight loss. This is the single most effective intervention: it reduces liver fat significantly, and 10% or more can reverse NASH and even early fibrosis.3 Patients underestimate how much change is needed and overestimate how fast the liver responds — think months, not weeks.
  3. Change what you eat, Mediterranean-style. Reduce refined carbohydrates, sugary drinks and fructose; increase vegetables, wholegrains, legumes, lean protein and olive oil — the most evidence-based eating pattern for fatty liver.
  4. Move — even before the scale moves. Both aerobic exercise and resistance training reduce liver fat independently of weight loss. Aim for 150+ minutes of moderate activity per week.
  5. Avoid alcohol during recovery. Even modest intake worsens fatty liver; complete abstinence is ideal while reversing it.
  6. Check the metabolic company it keeps. Ask about blood sugar, lipids and blood pressure — and when to retest liver enzymes to track progress.

Fatty liver grading

GradeFat in liver cellsBlood testsOutlook
Grade 1 (mild)5–33%ALT mildly elevated or normalFully reversible with lifestyle
Grade 2 (moderate)34–66%ALT moderately elevatedReversible; needs intervention
Grade 3 (severe)>66%ALT elevated; albumin may fallRisk of NASH and fibrosis
NASHSteatosis + inflammationALT/AST elevated; INR may riseProgresses to cirrhosis if untreated

Practical notes

Keep your liver function reports in date order and track ALT and AST across visits — these enzymes fluctuate, so the trend matters more than one reading. A simple weight record alongside is useful too, since gradual weight change and liver enzymes often move together.

Be candid with your doctor about alcohol — amount, frequency and for how long — because it directly shapes both diagnosis and advice. Also list all medicines and supplements (several can affect the liver), and bring your diabetes and cholesterol reports, since these conditions travel together.

The measures doctors discuss most are gradual sustained weight loss, regular physical activity, and cutting back or stopping alcohol — there are no quick fixes, despite what supplement advertisements claim. Crash diets can actually worsen liver fat, so discuss any diet plan with your doctor or a dietitian.

Follow-up usually means repeating liver enzymes and sometimes an ultrasound at intervals to see whether things are improving. If there are signs of more advanced disease, your doctor may suggest fibrosis assessment such as a FIB-4 calculation or elastography. Ask what your results mean for the monitoring schedule.

In India

In India, a liver function test panel typically costs around ₹500–₹1,000 at private labs, and an abdominal ultrasound around ₹800–₹1,800, though prices vary by city and facility. Elastography (FibroScan), where available, is a separate hospital charge — ask for an estimate if it is advised.

Choose a NABL-accredited lab for the blood work, and a reputed imaging centre for the ultrasound, since scan quality depends on the operator. Home sample collection is available in major cities. The reference range printed on your own report is the one that counts.

Frequently asked questions

Advertisement

What is fatty liver disease?

Non-alcoholic fatty liver disease (NAFLD) — now renamed metabolic dysfunction-associated steatotic liver disease (MASLD) — is excess fat accumulation in liver cells in people who drink little or no alcohol. It ranges from simple steatosis (fat only, usually benign) to NASH (fat plus inflammation) to fibrosis and cirrhosis. It is strongly linked to obesity, type 2 diabetes, insulin resistance and metabolic syndrome.

What is the difference between NAFLD and NASH?

NAFLD is the umbrella term. Simple steatosis is fat in more than 5% of liver cells without significant inflammation — benign in the majority. NASH (steatohepatitis) is fat plus inflammation and liver-cell injury; about 15–20% of those with simple steatosis develop NASH, and 15–25% of those with NASH progress to cirrhosis over 10–20 years. Blood tests alone cannot reliably distinguish the two.

How can fatty liver be reversed?

Sustained weight loss is the single most effective intervention: losing 7–10% of body weight reduces liver fat significantly, and 10% or more can reverse NASH and even early fibrosis. The Mediterranean diet is the most evidence-based eating pattern for fatty liver, and both aerobic exercise and resistance training reduce liver fat independently of weight loss. Complete alcohol abstinence is ideal during recovery.

Can blood tests alone diagnose or stage fatty liver?

Not reliably. ALT is elevated in 30–80% of cases, but up to 30% of patients with confirmed NASH have normal liver enzymes — ALT is a poor screening tool. The FIB-4 score, calculated from age, AST, ALT and platelets, is the recommended first-line non-invasive fibrosis tool: below 1.3 suggests low fibrosis risk, above 2.67 high risk. Ultrasound grades the fat; FibroScan (liver elastography) assesses fibrosis.

Is there a medicine that treats fatty liver?

There is currently no approved pharmacological treatment that works for all stages. Sustained weight loss outperforms everything else in the evidence — which is why guidelines treat it as the therapy, not just lifestyle advice. Discuss your full metabolic picture (blood sugar, lipids, blood pressure) with your doctor, since these travel together.

My liver enzymes are only mildly raised — does that mean serious damage?
Mild ALT or AST rises are common and often have reversible causes; enzyme levels alone do not measure the amount of liver damage. Your doctor puts them together with the ultrasound, your history and sometimes fibrosis assessment. Discuss what your specific numbers mean rather than worrying over the flag on the report.
Can fatty liver go away completely?
In its early stages, liver fat can improve substantially — and sometimes resolve — with sustained weight loss, activity and reduced alcohol. More advanced scarring is less reversible, which is why acting early matters. Discuss realistic expectations for your stage with your doctor.
Is ghee or cooking oil the main problem?
No single food is usually the culprit — overall calorie balance, weight and alcohol matter far more than whether you cook in ghee or oil. Crash dieting and ‘liver detox’ products are not the answer. Discuss a sustainable eating pattern with your doctor or dietitian.
Will I need a liver biopsy?
Usually not. Non-invasive assessments — blood-based scores like FIB-4 and elastography scans — come first and answer the question in most cases. Biopsy is reserved for situations where the non-invasive tests disagree or the diagnosis is unclear. Your doctor will explain if it is ever needed.

References

Sources cited on this page. PubMed links open the original abstract.

  1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357. PMID 28714183 · doi:10.1002/hep.29367
  2. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–1986. PMID 37363821 · doi:10.1097/HEP.0000000000000520
  3. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378. PMID 25865049 · doi:10.1053/j.gastro.2015.04.005
  4. Nonalcoholic Fatty Liver Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK482489
Medical Disclaimer: This page is for general educational purposes only and does not constitute medical advice. Always consult a qualified doctor for diagnosis and treatment.
Written and medically reviewed by Suman Konda, Clinical Pharmacist · Sources linked to PubMed · Not medical advice: see our disclaimer